Back to Search
Start Over
Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome.
- Source :
-
Biology of Blood & Marrow Transplantation . Jan2019, Vol. 25 Issue 1, p63-72. 10p. - Publication Year :
- 2019
-
Abstract
- Highlights • The 3-year GVHD-free, relapse-free survival rate for myelodysplastic syndrome was 34.5%. • Circulating blast, cytogenetics, HCT-CI, MAC/RIC, and ATG dose were factors predicting GRFS. • Risk-stratified GRFS rates were 64.9% in low-risk, 33.6% in intermediate-risk, and 6.6% in high-risk patients. • There was an evident impact of RIC and ATG ≥ 7. 5mg/kg on low-risk patients by the other 3 factors. • There was no evident impact of RIC and ATG ≥ 7.5 mg/kg on high-risk patients by the other 3 factors. Graphical Abstract Image, graphical abstract Abstract Graft-versus-host disease–free, relapse-free survival (GRFS) is a composite endpoint that measures survival free of relapse or significant morbidity after allogeneic hematopoietic stem cell transplantation (HSCT). Consecutive adult patients (N = 324) who received HSCT with fludarabine and busulfan–based conditioning for myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia evolved from MDS were retrospectively analyzed. One-year and 3-year GRFS rates were 47.8% and 34.5%, respectively. Three fixed factors (circulating blast > 3%, high cytogenetic risk, and high comorbidity index) and 2 factors (which are) modifiable by clinicians (myeloablative conditioning [MAC] and low-dose [<7.5 mg/kg] antithymocyte globulin [ATG]) were independent factors for poor GRFS. Based on these 5 factors, 3 groups (3-year GRFS: 64.9% in low risk, 33.6% in intermediate risk, and 6.6% in high risk; P <.001) were identified. Fixed factor–adjusted GRFS in patients receiving reduced-intensity conditioning (RIC) plus high-dose ATG (≥7.5 mg/kg) was superior (P <.001) to those receiving MAC and/or low-dose ATG. Favorable influences of RIC plus ATG ≥ 7.5 mg/kg were evident in the low-risk group defined by fixed factors (3-year GRFS, 38.9% versus 4.4%; P <. 001) but were not evident in the high-risk group (3-year GRFS,.0% versus 5.3%; P =.678). Conclusively, this study suggests that risk-adapted selection of conditioning intensity and ATG could improve qualified HSCT outcomes. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 10838791
- Volume :
- 25
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Biology of Blood & Marrow Transplantation
- Publication Type :
- Academic Journal
- Accession number :
- 133720992
- Full Text :
- https://doi.org/10.1016/j.bbmt.2018.08.004